Crystal structure of the Měnglà virus VP30 C-terminal domain

Area of Science:

• Virology
• Structural Biology
• Drug Discovery

Background:

• Filoviridae family includes significant human pathogens like Marburg virus (MARV) and Ebola virus (EBOV).
• Měnglà virus (MLAV), a recently identified filovirus, poses a potential threat as a human pathogen.
• The VP30 C-terminal domain (CTD) is vital for the assembly of these filoviruses.

Purpose of the Study:

• To determine the crystal structure of the recombinant MLAV VP30 CTD monomer.
• To investigate the role of the C-terminal helix-7 (H7) in the dimerization of MLAV VP30 CTD.
• To establish a preliminary model for targeting MLAV VP30 CTD in anti-filovirus drug development.

Main Methods:

• Recombinant expression and purification of MLAV VP30 CTD.
• X-ray crystallography to determine the monomer structure.
• Biochemical assays to assess dimerization properties.

Main Results:

• The crystal structure of the MLAV VP30 CTD monomer was successfully determined.
• The C-terminal helix-7 (H7) was identified as essential for the dimerization process of MLAV VP30 CTD.
• MLAV VP30 CTD primarily exists as a dimer in solution, similar to other filoviruses.

Conclusions:

• The structural insights into MLAV VP30 CTD provide a foundation for understanding filovirus assembly.
• The identified role of helix-7 in dimerization offers a potential target for antiviral strategies.
• This research paves the way for developing novel anti-filovirus therapeutics targeting MLAV VP30 CTD.